483
Octapharma Plasma, Inc.Octapharma Plasma, Inc. – FDA 483, Sep 23, 2019
Record Details
An FDA inspection of Octapharma Plasma, Inc.'s Source Plasma Donor Center in Forestville, MD, revealed a critical failure to maintain donor records. Specifically, the firm did not retain notification letters for deferred donors who tested positive for serious communicable diseases like HIV, HCV, and HBsAg. This lapse in record-keeping raises concerns about proper donor management and public health safety.
View Company Profile
ID · cfa93586-70c5-4674-8f0e-f07ce90a08e8
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.